The Georgia Senate promotes invoices to regulate the products and to expand access to medical cannabis

Georgia's Senate recently adopted three significant legislative templates that aim to tighten the regulations for THC-infused products and to expand access to medical cannabis. These legislative moves reflect concerted efforts in order to reconcile the security of consumers with the needs of the patient in the developing landscape of cannabis consumption.

Stricter regulations for THC products

The Senate Act 254 introduced by Senator Bill Cowsert originally contested the amount of the DELTA 9-THC to limited in consumables hemp products. However, a change at the last minute led to a complete ban on all drinks that contain THC. Cowser said concerns about the psychoactive effects of THC and compares a single 10 mg that looked at the consumption of four glasses of wine. The law was passed with a mood of 42 to 14, which indicates two -party support despite some opposition.

In addition, Senate Bill 33, sponsored by Senator Kay Kirkpatrick, aims to improve consumer protection by regulating intoxicating cannabinoids such as Delta-8, Delta-10 and Delta-11. The invoice submits these substances to the same 0.3% THC concentration limit as Delta-9 and prescribes random state inspections of hemp products for consumables. Kirkpatrick emphasized the concerns about the contamination of non -regulated producers and emphasized the focus of the law on the security of consumers. This measure was expired with minimal resistance and received a vote of 50-6.

Expansion of the access of medical cannabis

In the medical front, the Law of Senate 220, known as “Georgia's patient, the first law”, proposes significant changes to the state's medical cannabis program. The invoice increases the permissible concentration of cannabidiol in medical cannabis from 5% to 50% and at the same time reduces the limit of legal property to two ounces. It also adds diseases such as cancer and lupus to the list of qualifying health problems and eliminates the requirement that certain diseases are serious or end stage for treatment. Although some oppositions reported concerns about long -term health effects, the legislation was passed with a mood of 39 to 17, which was supported by members across party borders.

Next Steps

All three invoices have moved to the House of Representatives of Georgia for examination. The legislative period is to be completed on April 4, so that a limited window is enacted to the law for these measures.